Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma
Lamm, Wolfgang, Kiesewetter, Barbara, Puhr, Hannah, Dolak, Werner, Mayerhöfer, Marius E., Raderer, MarkusLanguage:
english
Journal:
Annals of Hematology
DOI:
10.1007/s00277-018-3588-y
Date:
December, 2018
File:
PDF, 306 KB
english, 2018